HGV/GB virus C transmission by blood components in patients undergoing open-heart surgery

Transfusion

Volumn 43, Issue 11, 2003, Pages 1558-1562

  Sentjens, Roel ^b   Basaras, Miren ^b   Simmonds, Peter ^b   Vrielink, Hans ^b   Reesink, Henk ^a  

^a Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS G VIRUS; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN HEART SURGERY; POLYMERASE CHAIN REACTION; VIRUS TRANSMISSION;

ANTIBODIES; ANTIGENS, CD; BLOOD COMPONENT TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CELL ADHESION MOLECULES; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HUMANS; RNA, VIRAL;

EID: 0242440035     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00561.x     Document Type: Article

References (27)

1. Alter HJ, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease [see comments]. N Engl J Med 1997;336:747-54.
2. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.
3. Leary TP, Muerhoff AS, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-7.
4. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
5. Muerhoff AS, Leary TP, Simons JN, et al. Genomic organization of GB viruses A and B. two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995;69:5621-30.
6. Roth WK, Waschk D, Marx S, et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 1997;37:651-6.
7. Yoshikawa A, Fukuda S, Itoh K, et al. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan. Transfusion 1997;37:657-63.
8. Bassit L, Kleter B, Ribeiro-dos-Santos G, et al. Hepatitis G virus: prevalence and sequence analysis in blood donors of Sao Paulo, Brazil. Vox Sang 1998;74(2):83-7.
9. Tucker TJ, Louw SJ, Robson SC, et al. High prevalence of GBV-C hepatitis G virus infection in a rural South African population. J Med Virol 1997;53:225-8.
10. Karayiannis P, Pickering J, Zampino R, Thomas HC. Natural history and molecular biology of hepatitis G virus/GB virus C. Clin Diagn Virol 1998;10(2-3):103-11.
11. Lin HH, Kao JH, Yeh KY, et al. Mother-to-infant transmission of GB virus C/hepatitis G virus: the role of high-titered maternal viremia and mode of delivery. J Infect Dis 1998;177:1202-6.
12. Yeo AE, Matsumoto A, Shih JW, et al. Prevalence of hepatitis G virus in patients with hemophilia and their steady female sexual partners. Sex Transm Dis 2000;27(3):178-82.
13. Martin P, Fabrizi F, Dixit V, et al. Epidemiology and natural history of hepatitis G virus infection in chronic hemodialysis patients. Am J Nephrol 1999;19:535-40.
14. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001;345:715-24.
15. Xiang J, Wunschmann S, Diekema DJ, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001;345:707-14.
16. Tucker TJ, Smuts HE, Eedes C, et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 2000;61:52-8.
17. Fogeda M, Navas S, Martin J, et al. In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol 1999;73:4052-61.
18. Kobayashi M, Tanaka E, Nakayama J, et al. Detection of GB virus-C/hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue. J Med Virol 1999;57(2):114-21.
19. Gutierrez RA, Dawson GJ, Mushahwar IK. ELISA for detection of antibody to the E2 protein of GB virus C. J Virol Meth 1997;69:1-6.
20. Tacke M, Schmolke S, Schlueter V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997;26:1626-33.
21. Van der Poel CL, Reesink HW, Lelie PN, et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 1989;2:297-8.
22. Jarvis LM, Watson HG, McOmish F, et al. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis 1994;170:1018-22.
23. Jarvis LM, Davidson F, Hanley JP, et al. Infection with hepatitis G virus among recipients of plasma products [see comments]. Lancet 1996;348:1352-5.
24. Mellor J, Holmes EC, Jarvis LM, et al. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. J Gen Virol 1995;76:2493-507.
25. Simmonds P, Smith DP. Structural constraints on RNA virus evolution. J Virol 1999;73:5787-94.
26. MEGA. Molecular evolutionary genetics analysis, version 1.0. Pennsylvania State University, Pennsylvania, 1993.
27. Sauleda S, Esteban JI, Hernandez JM, et al. Evaluation of RNA and E2 antibodies in prospectively followed recipients of hepatitis G virus-infected blood. Transfusion 1999;39:633-8.